Compare, Analyse Jubilant Pharmova with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    ACTAVIS
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
ACTAVIS
Dec-18
JUBILANT PHARMOVA /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs72714,387-   
Low Rs2309,651-   
Sales per share (Unadj.) Rs574.73,529.1-  
Earnings per share (Unadj.) Rs56.4-1,136.7-  
Cash flow per share (Unadj.) Rs85.4371.9-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs351.814,555.7-  
Shares outstanding (eoy) m159.28332.60-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.83.4 24.4%   
Avg P/E ratio x8.5-10.6 -80.3%  
P/CF ratio (eoy) x5.632.3 17.3%  
Price / Book Value ratio x1.40.8 164.7%  
Dividend payout %8.90-   
Avg Mkt Cap Rs m76,2203,997,412 1.9%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m21,2770-   
Avg. sales/employee Rs ThNM69,453.5-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-22,371.0-  
INCOME DATA
Net Sales Rs m91,5441,173,763 7.8%  
Other income Rs m47422,446 2.1%   
Total revenues Rs m92,0181,196,210 7.7%   
Gross profit Rs m19,12430,759 62.2%  
Depreciation Rs m4,619501,758 0.9%   
Interest Rs m2,87467,733 4.2%   
Profit before tax Rs m12,105-516,286 -2.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0131,674 0.0%   
Tax Rs m3,123-6,543 -47.7%   
Profit after tax Rs m8,982-378,070 -2.4%  
Gross profit margin %20.92.6 797.2%  
Effective tax rate %25.81.3 2,035.7%   
Net profit margin %9.8-32.2 -30.5%  
BALANCE SHEET DATA
Current assets Rs m50,383481,416 10.5%   
Current liabilities Rs m26,190425,877 6.1%   
Net working cap to sales %26.44.7 558.5%  
Current ratio x1.91.1 170.2%  
Inventory Days Days720 33.3%  
Debtors Days Days5266 77.8%  
Net fixed assets Rs m72,721132,863 54.7%   
Share capital Rs m1590-   
"Free" reserves Rs m55,8800-   
Net worth Rs m56,0394,841,226 1.2%   
Long term debt Rs m37,3971,704,771 2.2%   
Total assets Rs m123,1047,567,938 1.6%  
Interest coverage x5.2-6.6 -78.7%   
Debt to equity ratio x0.70.4 189.5%  
Sales to assets ratio x0.70.2 479.5%   
Return on assets %9.6-4.1 -234.9%  
Return on equity %16.0-7.8 -205.3%  
Return on capital %16.0-4.8 -331.2%  
Exports to sales %00-   
Imports to sales %14.80-   
Net fx Rs m2,0000-   
CASH FLOW
From Operations Rs m15,429419,341 3.7%  
From Investments Rs m-3,270230,373 -1.4%  
From Financial Activity Rs m-10,504-719,715 1.5%  
Net Cashflow Rs m2,254-69,651 -3.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.35 Rs / USD

Compare JUBILANT PHARMOVA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare JUBILANT PHARMOVA With: BAFNA PHARMA  UNJHA FORMUL  ROOPA INDUSTRIES  AAYUSH FOOD & HERBS   COMBAT DRUGS  



Today's Market

5 Factors Why Stock Markets Surged, Adani Wilmar's IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices came out of their long slumber.

Related Views On News

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks (Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

The Road to 100 Baggers Begins Here (Profit Hunter)

Jul 22, 2021

How to be an early investor in future 100 baggers.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

JUBILANT PHARMOVA SHARE PRICE


Aug 3, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 8-QTR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

FEATURED VIDEOS

India's Best Drone Stocks

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

More Featured Videos

MARKET STATS